FRANK DANIEL

CIK 00011640072 companiesNEW YORK, NY

Transactions

Companies

Filings

CIK

0001164007

Recent Transactions

11 trades

Award
Molecular Insight Pharmaceuticals, Inc.
Stock Option (right to buy)
2010-05-13−25,000→ 25,000 total
Will/Inheritance
Molecular Insight Pharmaceuticals, Inc.
Common Stock
2009-10-06+3,679→ 146,959 total
Award
Molecular Insight Pharmaceuticals, Inc.
Stock option (right to buy)
2009-05-12+25,000→ 25,000 total
Award
Molecular Insight Pharmaceuticals, Inc.
Stock Option (right to buy)
2007-06-26+25,000→ 25,000 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock, par value $0.01 per share
2007-02-01+54,367→ 126,487 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2007-02-01−1,894→ 0 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2007-02-01−1,488→ 0 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock, par value $0.01 per share
2007-02-01+12,626→ 139,113 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock Purchase Warrant (right to buy)
2007-02-01$3.96/sh−12,626→ 0 total
Conversion
Molecular Insight Pharmaceuticals, Inc.
Common Stock, par value $0.01 per share
2007-02-01+72,120→ 72,120 total
Disposition from Tender
I STAT CORPORATION /DE/
Common Stock, par value $0.15 per share
2004-01-28$15.35/sh−96,200→ 0 total

C/O CERBERUS CAPITAL MANAGEMENT, L.P. 299 PARK AVENUE, 22ND FLOOR

NEW YORK, NY, 10171